Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Factors Influencing Drug Absorption: Disease States and Pharmacology

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

Drug Administration and Therapy Phases: Overview

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Study of the impact of a post-acute coronary syndrome pharmaceutical interview in hospital].

Annales pharmaceutiques francaises·2022

Same author

Security and reliability of CUSTOMBONE cranioplasties: A prospective multicentric study.

Neuro-Chirurgie·2021

Same author

Impact of the COVID-19 pandemic on clinical research in hospitals: observational study in the first epicenter of the epidemic during the general lockdown in France.

European review for medical and pharmacological sciences·2021

Same author

[Evaluation of the implantation of a de-prescribing process for proton pump inhibitor (PPI) using an algorithm within an internal medicine department].

La Revue de medecine interne·2020

Same author

Subcutaneous teicoplanin in staphylococcal bone and joint infections.

Medecine et maladies infectieuses·2019

Same author

Clinical antifungal efficacy trials in invasive aspergillosis: Consensus standards for trial design and room for improvement.

Medical mycology·2018

Same journal

No evidence of significant natural environmental exposure to arsenic for Napoleon I on the island of Saint Helena (1815-1821).

Annales pharmaceutiques francaises·2026

Same journal

EFFECTS OF GLP-1 RECEPTOR AGONISTS ON PERIODONTAL TISSUE: AN INTERDISCIPLINARY EVIDENCE MAPPING - SCOPING REVIEW.

Annales pharmaceutiques francaises·2026

Same journal

Regulatory non-compliance of parallel imported medicines in Kenya and implications for public health: Evidence from Nairobi County.

Annales pharmaceutiques francaises·2026

Same journal

Prostaglandin analogues in cosmetic products formulated for eyelash lengthening.

Annales pharmaceutiques francaises·2026

Same journal

Mechanistic and thermodynamic evaluation of sodium citrate-mediated hydrotropism for the biopharmaceutical optimization of BCS Class II drug atorvastatin calcium.

Annales pharmaceutiques francaises·2026

Same journal

Future trends and the role of artificial intelligence in pharmaceutical project management.

Annales pharmaceutiques francaises·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 30, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

[Clinical pharmacy and surgery: Review].

A Jarfaut¹, Y Nivoix¹, D Vigouroux²

¹Service de pharmacie, hôpitaux universitaires de Strasbourg, 1, avenue Molière, 67098 Strasbourg, France.

Annales Pharmaceutiques Francaises

|May 1, 2014

Summary

This summary is machine-generated.

Clinical pharmacy services in surgical settings optimize patient drug management and reduce adverse events. This review highlights key activities and indicators, confirming clinical and economic value.

Keywords:

Activities Activités Chirurgie Clinic Clinique Impact Indicateurs Indicators Pharmacie Pharmacy Surgery

Related Experiment Videos

Last Updated: Apr 30, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Area of Science:

Clinical Pharmacy
Surgical Services
Drug Management

Context:

Clinical pharmacy is integral to hospital activities, with reviews showing significant value.
Surgical services face risks of adverse drug events, necessitating optimized pharmaceutical care.
Previous research focused on medical patients, leaving surgical patient care less explored.

Purpose:

To profile clinical pharmacy activities in surgical services.
To identify key performance indicators for clinical pharmacy in surgery.
To evaluate the impact of clinical pharmacy on surgical patient outcomes.

Summary:

A literature review of 21 English or French papers (2000-2013) from PubMed focused on clinical pharmacy in surgery.
Predominant activities included medication history and therapeutic drug monitoring (antibiotics, anticoagulants).
Identified indicators comprised activity metrics (interventions, acceptance rates, workload) and impact metrics (clinical, economic).

Impact:

Clinical pharmacy development in surgical patient care is documented.
Evidence suggests clinical pharmacy provides significant clinical and economic value, similar to medical patient care.
Optimized drug management in surgery can lead to improved patient safety and healthcare economics.